Stereocontrolled syntheses of epimeric 3-aryl-6-phenyl-1-oxa-7-azaspiro[4.5]decane NK-1 receptor antagonist precursors

Organic Letters

Volumn 3, Issue 5, 2001, Pages 667-670

  Kulagowski, Janusz J ^a   Curtis, Neil R ^a   Swain, Christopher J ^a   Williams, Brian J ^a  

^a NEUROSCIENCE RESEARCH CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 ARYL 6 PHENYL 1 OXA 7 AZASPIRO(4.5)DECANE; 3-ARYL-6-PHENYL-1-OXA-7-AZASPIRO(4.5)DECANE; HETEROCYCLIC COMPOUND; LIGAND; NEUROKININ 1 RECEPTOR; SPIRO COMPOUND;

ARTICLE; DRUG ANTAGONISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; STEREOISOMERISM; SYNTHESIS;

AZA COMPOUNDS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; LIGANDS; MAGNETIC RESONANCE SPECTROSCOPY; RECEPTORS, NEUROKININ-1; SPIRO COMPOUNDS; STEREOISOMERISM;

EID: 0035826346     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol006944a     Document Type: Article

References (19)

1. Swain, C. J. In Progress in Medicinal Chemistry; Ellis, G. P., Luscombe, D. K., Oxford, A. W., Eds.; Elsevier Science BV: Amsterdam, 1998; Vol. 35, p 57.
2. Snider, R. M.; Constantine, J. W.; Lowe, J. A., III; Longo, K. P.; Lehel, W. S.; Woody, H. A.; Drozda, S. E.; Desai, M. C.; Vinick, F. J.; Spencer, R. W.; Hess, H.-J. Science 1991, 251, 435.
3. Kramer, M. S.; Cutler, N.; Feighner, J.; Shrivastava, R.; Carman, J.; Sramek, J. J.; Reines, S. A.; Liu, G.; Snavely, D.; Wyatt-Knowles, E.; Hale, J. J.; Mills, S. G.; MacCoss, M.; Swain, C. J.; Harrison, T.; Hill, R. G.; Hefti, F.; Scolnick, E. M.; Cascieri, M. A.; Chicchi, G. G.; Sadowski, S.; Williams, A. R.; Hewson, L.; Smith, D.; Carlson, E. J.; Hargreaves, R. J.; Rupniak, N. M. J. Science 1998, 281, 1640.
4. 1 Antagonists. Book of Abstracts, Tachykinins 2000; Phvsiology, Drug Discovery and Clinical Applications, La Grande Motte, France, 2000; poster P84.
5. (b) Baker, R.; Curtis, N. R.; Elliott, J. M.; Harrison, T.; Hollingworth, G. J.; Jackson, P. S.; Kulagowski, J. J.; Seward, E. M.; Swain, C. J.; Williams, B. J. WO 97/49710, 1997; Chem Abstr. 1998, 128, 88921.
6. Harrison, T.; Williams, B. J.; Swain, C. J.; Ball, R. G. Bioorg. Med. Chem. Lett. 1994, 4, 2545.
7. Miyake, H.; Yamamura, K. Chem. Lett. 1989, 981.
8. (a) Burns, B.; Grigg, R.; Sarnhakumar, V.; Sridharan, V.; Stevenson, P.; Worakun, T. Tetrahedron 1992, 48, 7297.
9. (b) Veenstra, S. J.; Hauser, K.; Betschart. Bioorg. Med. Chem. Lett. 1997, 7, 347.
10. (c) Clayton, S. C.; Regan, A. C. Tetrahedron Lett. 1993, 34, 7493.
11. Heck, R. F. In Organic Reactions; Dauben, W. G. Ed.; John Wiley & Sons: New York, 1982; Vol. 27, p 345.
12. Larock, R. C.; Johnson, P. L. J. Chem. Soc., Chem. Commun. 1989, 1368.
13. Stokker, G. E. Tetrahedron Lett. 1987, 28, 3179.
14. Kojima, A.; Honzawa, S.; Boden, C. D. J.; Shibasaki, M. Tetrahedron Lett. 1997, 38, 3455.
15. Abelman, M. M.; Oh, T.; Overman, L. E. J. Org. Chem. 1987, 52, 4130.
16. For examples in which added halide ions affect the outcome of Heck reactions, see: (a) Merlic, C. A.; Semmelhack, M. F. J. Organomet. Chem., 1990, 391, C23.
17. (b) Andersson, C.-M.; Hallberg, J. Org. Chem. 1988, 53, 2112.
18. (a) Larock, R. C.; Gong, W. H. J. Org. Chem. 1990, 55, 407.
19. (b) Daves, G. D., Jr.; Hallberg, A. Chem. Rev. 1989, 89, 1433.